FAIR ISAAC CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data FAIR ISAAC CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	881	935	1,032	1,160	1,295	1,317	1,377	1,514	1,718	1,991
Cost of revenue	265	288	313	337	361	332	302	311	348	354
Gross profit	616	647	720	823	933	984	1,075	1,203	1,369	1,637
Research and development	104	111	128	149	166	171	147	160	172	188
Selling, general and administrative	329	337	377	414	421	396	384	401	463	513
Selling and marketing	3.6	3.1	4.1	3.6	8.7	6.9	8.1	9.8	12.3	29.7
Operating income	170	182	175	254	296	505	542	643	734	925
Interest expense	26.6	25.8	31.3	39.8	42.2	40.1	69	95.5	106	134
Other non-operating income	1.61	-0.09	12.9	2.28	3.21	7.75	-2.14	6.34	14	11.4
Pre-tax income	145	156	157	216	257	473	471	554	642	803
Income tax	35.1	22.9	30.5	23.9	20.6	81.1	97.8	124	129	151
Net income	109	133	126	192	236	392	374	429	513	652
EBITDA	201	218	206	285	326	531	563	657	747	940
EPS, basic	3.66	4.32	4.26	6.63	8.13	13.65	14.34	17.18	20.78	26.90
EPS, diluted	3.53	4.14	4.06	6.34	7.90	13.40	14.18	16.93	20.45	26.54
Shares, basic (weighted)	29.9	30.9	29.7	29	29.1	28.7	26	25	24.7	24.2
Shares, diluted (weighted)	31.1	32.2	31.2	30.3	29.9	29.3	26.3	25.4	25.1	24.6

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	75.9	106	90	106	157	195	133	137	151	134
Receivables	168	169	267	297	334	312	322	388	427	529
Other current assets	23.9	36.7	39.6	51.9	42.5	43.5	29.1	31.7	40.1	41.9
Total current assets	268	311	396	456	534	551	485	556	617	705
Property, plant and equipment	45.1	40.7	48.8	53	46.4	27.9	17.6	11	38.5	67.7
Lease right-of-use assets					57.7	47.3	36.7	25.7	29.6	26.2
Goodwill	798	804	801	804	812	788	761	773	783	783
Intangible assets	33.6	21.2	14.5	14.1	9.24	4.1	2.02	0.92	0
Long-term investments		13.8	18.1	20.2	25.5	31.9	24.5	33	45.3	54.6
Other non-current assets	6.35	5.67	36.3	79.2	105	95.6	103	116	118	113
Total assets	1,221	1,256	1,330	1,433	1,606	1,568	1,442	1,575	1,718	1,868
Accounts payable	23	19.5	20.3	23.1	23	20.7	17.3	19	22.5	32.3
Accrued liabilities	27.8	32.1	31	32.5	63.4	79.5	66.2	59.5	79.8	115
Deferred revenue	47.1	55.4	103	111	115	105	120	137	157	187
Short-term debt	77	142	235	218	95	250	30	50	15	400
Total current liabilities	246	327	474	491	415	559	331	368	380	849
Long-term debt	494	463	529	607	739	1,009	1,824	1,812	2,194	2,656
Lease liabilities					73.2	53.7	39.2	23.9	22	19.2
Other non-current liabilities				46.1	48	56.8	49.7	60	84.3	89.4
Total liabilities	774	829	1,043	1,144	1,275	1,679	2,244	2,263	2,681	3,614
Total debt	494	463	529	607	739	1,009	1,824	1,812	2,209	3,056
Paid-in capital	1,189	1,195	1,211	1,225	1,219	1,237	1,300	1,351	1,367	1,331
Retained earnings	1,471	1,598	1,765	1,957	2,193	2,585	2,959	3,388	3,901	4,553
Treasury stock	-2,137	-2,301	-2,612	-2,802	-2,998	-3,858	-4,936	-5,325	-6,139	-7,538
Other comprehensive income	-77	-66.5	-76.4	-90.1	-83	-75.9	-125	-102	-91.6	-92.1
Shareholders' equity	481	466	287	290	331	-111	-802	-688	-963	-1,746
Total equity	481	466	287	290	331	-111	-802	-688	-963	-1,746
Total liabilities and equity	1,221	1,256	1,330	1,433	1,606	1,568	1,442	1,575	1,718	1,868
Shares outstanding	29.7	30.2	29	28.9	29.1	27.6	25.2	24.8	24.4	23.8

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	109	133	126	192	236	392	374	429	513	652
Depreciation and amortization	31.6	36.2	30.2	31.6	30.4	25.6	20.5	14.6	13.8	15
Stock-based compensation	55.5	61.2	74.8	83	93.7	112	115	124	149	157
Deferred income tax	-26	-6.25	10.6	7.7	-8.64	-5.96	7.82	-47.4	-27.3	-32.5
Change in receivables	-18.2	2.86	-8.27	-36.2	-59.9	24.5	-31.6	-70.1	-34.1	-100
Change in payables	0.56	-2.03	0.84	1.89	1.06	-2.35	-2.8	2.24	3.32	9.85
Cash from operations	210	226	223	260	365	424	509	469	633	779
Capital expenditures	-22	-19.8	-31.3	-24	-22	-7.57	-6.03	-4.24	-8.88	-8.92
Acquisitions	-5.68	0	0	-15.9	0	0
Purchases of investments	0	0	-6.05	-6.4	-6.12	-9.04	-9.96	-10.6	-18.4	-6.5
Sales and maturities of investments	0	0	3.23	3.48	3.47	7.24	8.06	5.03	15.9	2.18
Cash from investing	-27.6	-20.6	-14.1	-42.8	-24.6	138	-5.67	-16	-28	-43.7
Debt issued	0	0	400	0	350	0	550	0	0	1,500
Stock issued		14.5	11	22.8	25.4	4.4	3.2	8.1	8.3	14.7
Share buybacks	-138	-188	-343	-229	-235	-874	-1,104	-406	-822	-1,415
Dividends paid	-2.49	-1.24	0	0
Cash from financing	-190	-181	-219	-200	-289	-524	-547	-455	-593	-750
Exchange rate effect	-2.83	5.28	-5.9	-1.14	0.06	-0.14	-18.8	5.62	1.84	-1.29
Net change in cash	-10.2	29.7	-15.6	16.4	51	38	-62.2	3.58	13.9	-16.5
Free cash flow	188	206	192	236	343	416	503	465	624	770
Interest paid	26.9	26.1	26.1	39.9	37.7	38	57.2	96.9	106	104
Income taxes paid	10.9	31.3	13.4	18.8	10.2	71.5	65.3	153	134	162

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $863.09 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	85.1%	Gross profit / revenue.
Operating margin	51.7%	Operating income / revenue.
EBITDA margin	52.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	44.5%	Pre-tax income / revenue.
Net margin	34.1%	Net income / revenue.
FCF margin	41.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	41.8%	Cash from operations / revenue.
Effective tax rate	23.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	40.0%	Net income / average total assets.
Return on invested capital (ROIC)	76.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	8.7%	Research and development expense / revenue.
SG&A / revenue	24.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	7.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.2%	Capital expenditures / revenue.
D&A / revenue	0.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	15.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	13.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	9.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	19.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	15.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	11.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	26.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	19.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	25.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	25.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	18.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	23.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	27.1%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	20.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	22.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	29.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	23.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	27.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	23.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	15.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	16.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	23.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	15.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	17.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	8.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	9.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	3.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-2.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-3.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.18x	Current assets / current liabilities.
Quick ratio	1.13x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.33x	(Cash + short-term investments) / current liabilities.
Debt / assets	274.0%	Total debt / total assets.
Liabilities / assets	301.1%	Total liabilities / total assets.
Net debt	$5.33B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	4.27x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	6.63x	Operating income / interest expense.
Working capital	$136.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	38.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$4.89B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.17x	Revenue / average total assets.
Fixed asset turnover	26.3x	Revenue / average property, plant and equipment.
Receivables turnover	4.04x	Revenue / average receivables.
Days sales outstanding	90 days	365 x average receivables / revenue.
Days payables	28 days	365 x average accounts payable / cost of revenue.
FCF conversion	122.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	0.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$35.90	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$105.43	Revenue / diluted weighted shares.
FCF per share	$43.87	Free cash flow / diluted weighted shares.
Operating cash flow per share	$44.12	Cash from operations / diluted weighted shares.
Book value per share	-$189.71	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$226.37	Tangible book value / shares outstanding.
Cash per share	$11.50	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	360.8%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$18.64B	Share price x shares outstanding.
Enterprise value	$23.97B	Market cap + total debt - cash - short-term investments.
P/E	22.9x	Market cap / net income. Only when net income is positive.
P/S	7.79x	Market cap / revenue.
P/FCF	18.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	18.6x	Market cap / cash from operations, when positive.
EV/Sales	10.0x	Enterprise value / revenue.
EV/EBIT	19.4x	Enterprise value / operating income, when both are positive.
EV/EBITDA	19.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	24.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	5.3%	Free cash flow / market cap.
Earnings yield	4.4%	Net income / market cap (the inverse of P/E).
Shareholder yield	19.3%	(Dividends paid + share buybacks) / market cap.
PEG	0.98x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was FAIR ISAAC CORP's revenue in fiscal 2025?

FAIR ISAAC CORP reported revenue of $1.99B for fiscal 2025, 15.9% higher than the year before.

Was FAIR ISAAC CORP profitable in fiscal 2025?

Yes. Net income was $651.9M, a net margin of 32.7%.

How much free cash flow did FAIR ISAAC CORP generate in fiscal 2025?

Cash from operations of $778.8M minus capital expenditures of $8.9M left free cash flow of $769.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to FAIR ISAAC CORP